Pharmaceuticals news FT.com

Germany’s Merck to buy US biotech SpringWorks for $3.9bn

Pharmaceutical group says deal will help it establish leadership in rare tumours

Apr 28, 2025 - 09:02
 0
Germany’s Merck to buy US biotech SpringWorks for $3.9bn
Pharmaceutical group says deal will help it establish leadership in rare tumours
Read More

Tags:

Previous Article

APAC meetings industry trends: Regional update for Q1 2025

Next Article

Human medicines European public assessment report (EPAR): Dazublys, trastuzumab,...

Related Posts

Pfizer to halt development of closely watched weight-loss drug

Pfizer to halt development of closely watched weight-lo...

Apr 26, 2025  0

Trade war could put the frown back on Botox users’ faces

Trade war could put the frown back on Botox users’ faces

Apr 26, 2025  0

Top US vaccine official resigns over Kennedy’s ‘misinformation and lies’

Top US vaccine official resigns over Kennedy’s ‘misinfo...

Apr 26, 2025  0